HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19

Background - hyperbaric oxygen therapy (HBOT) is a clinical method of treatment with oxygen while under increased atmospheric pressure. It has been proven as an independent therapeutic factor for a number of diseases, and in the case of COVID-19, its potential as an adjuvant therapy is still being s...

Full description

Bibliographic Details
Main Authors: Diana Paskaleva, Vasilka Gyurova-Kancheva, Slavka Kacarova, Bozhidar Pilichev, Okean Kostov, Maria Bozhkova, Dimitar Penkov
Format: Article
Language:English
Published: Peytchinski Publishing 2023-10-01
Series:Journal of IMAB
Subjects:
Online Access:https://www.journal-imab-bg.org/issues-2023/issue4/2023vol29-issue4-5150-5153.pdf
_version_ 1797661861465817088
author Diana Paskaleva
Vasilka Gyurova-Kancheva
Slavka Kacarova
Bozhidar Pilichev
Okean Kostov
Maria Bozhkova
Dimitar Penkov
author_facet Diana Paskaleva
Vasilka Gyurova-Kancheva
Slavka Kacarova
Bozhidar Pilichev
Okean Kostov
Maria Bozhkova
Dimitar Penkov
author_sort Diana Paskaleva
collection DOAJ
description Background - hyperbaric oxygen therapy (HBOT) is a clinical method of treatment with oxygen while under increased atmospheric pressure. It has been proven as an independent therapeutic factor for a number of diseases, and in the case of COVID-19, its potential as an adjuvant therapy is still being studied. Case report – in the case of a 61-year-old man with severe pneumonia resulting from infection with COVID-19 and persisting hypoxemia and dyspnea after the acute phase. Prescribed continuous oxygenation in home conditions due to deteriorating general condition and quality of life. Undertaken additional hyperbaric oxygen therapy resulting in significant improvement after the 20th session. Conclusion - the connection between HBOT and improved paraclinical and imaging indicators, in this case, suggests conclusions of a therapeutic effect of HBOT in hypoxemia as a post-COVID symptom .
first_indexed 2024-03-11T18:50:55Z
format Article
id doaj.art-99509ff809af456e934e1cd74b1218c5
institution Directory Open Access Journal
issn 1312-773X
language English
last_indexed 2024-03-11T18:50:55Z
publishDate 2023-10-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj.art-99509ff809af456e934e1cd74b1218c52023-10-11T11:01:58ZengPeytchinski PublishingJournal of IMAB1312-773X2023-10-012945150515310.5272/jimab.2023294.5150HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19Diana Paskaleva0https://orcid.org/0000-0002-4581-6527Vasilka Gyurova-Kancheva1https://orcid.org/0009-0005-2141-088XSlavka Kacarova2https://orcid.org/0009-0002-2272-1258Bozhidar Pilichev3https://orcid.org/0000-0002-2077-0139Okean Kostov4https://orcid.org/0000-0001-8388-1605Maria Bozhkova5https://orcid.org/0000-0002-9115-3437Dimitar Penkov6https://orcid.org/0000-0003-1575-350XDepartment of Nursing Care, Faculty of Public Health, Medical University of Plovdiv, Bulgaria.Department of Nursing Care, Faculty of Public Health, Medical University of Plovdiv, Bulgaria.Unihospal Panaguirishte, Bulgaria.Department of Oral Surgery, Faculty of Dental Medicine, Medical University of Plovdiv, Bulgaria.Department of Nursing Care, Faculty of Public Health, Medical University of Plovdiv, Bulgaria.Department of Rehabilitator, Medical College, Medical University of Plovdiv, BulgariaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, Bulgaria.Background - hyperbaric oxygen therapy (HBOT) is a clinical method of treatment with oxygen while under increased atmospheric pressure. It has been proven as an independent therapeutic factor for a number of diseases, and in the case of COVID-19, its potential as an adjuvant therapy is still being studied. Case report – in the case of a 61-year-old man with severe pneumonia resulting from infection with COVID-19 and persisting hypoxemia and dyspnea after the acute phase. Prescribed continuous oxygenation in home conditions due to deteriorating general condition and quality of life. Undertaken additional hyperbaric oxygen therapy resulting in significant improvement after the 20th session. Conclusion - the connection between HBOT and improved paraclinical and imaging indicators, in this case, suggests conclusions of a therapeutic effect of HBOT in hypoxemia as a post-COVID symptom .https://www.journal-imab-bg.org/issues-2023/issue4/2023vol29-issue4-5150-5153.pdfhypoxemiacovid-19hyperbaric oxygen therapyquality of life
spellingShingle Diana Paskaleva
Vasilka Gyurova-Kancheva
Slavka Kacarova
Bozhidar Pilichev
Okean Kostov
Maria Bozhkova
Dimitar Penkov
HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
Journal of IMAB
hypoxemia
covid-19
hyperbaric oxygen therapy
quality of life
title HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
title_full HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
title_fullStr HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
title_full_unstemmed HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
title_short HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
title_sort hyperbaric oxygen therapy hbot as the treatment of prolonged hypoxemia due to covid 19
topic hypoxemia
covid-19
hyperbaric oxygen therapy
quality of life
url https://www.journal-imab-bg.org/issues-2023/issue4/2023vol29-issue4-5150-5153.pdf
work_keys_str_mv AT dianapaskaleva hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19
AT vasilkagyurovakancheva hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19
AT slavkakacarova hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19
AT bozhidarpilichev hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19
AT okeankostov hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19
AT mariabozhkova hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19
AT dimitarpenkov hyperbaricoxygentherapyhbotasthetreatmentofprolongedhypoxemiaduetocovid19